7: Diabetes and Epigenetics









References*
- Genomics and Precision Health. What is Epigenetics. CDC (2020).
- Elnitski L. Epigenetics. NHGRI (n.d.).
- Epigenetics: Fundamentals. What is Epigenetics (n.d.).
- Marks L. Epigenetics. What is Biotechnology (2017).
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 33(Suppl 1): S62-S69 (2010).
- DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 391(10138): 2449-2462 (2018).
- Cardiovascular Diseases. WHO (n.d.).
- Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017; 389(10085): 2239-2251 (2017).
- Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 57(2): 176-185 (2011).
- Ling C, Rönn T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metab. 29(5):1028-1044 (2019).
- Diabetes in Canada. Diabetes Canada (2020).
- Diabetes Overview: Complications. ADA (n.d.).
- Meruvu S, Bowman JD, Choudhury M. Chapter 20 – Healthy Aging and Epigenetic Drugs for Diabetes and Obesity: A Novel Perspective. Epigenetics of Aging and Longevity. 4: 419-438 (2018).
- Arguelles AO, Meruvu S, Bowman JD, Choudhury M. Are epigenetic drugs for diabetes and obesity at our door step.Drug Discov Today. 21(3): 499-509 (2016).
- University of Birmingham. Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome. NIH (2020).
- Villeneuve LM, Reddy MA, Natarajan R. Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol. 38(7):451-459 (2011).
- Heerboth S, Lapinska K, Snyder N, Leary M, Rollinson S, Sarkar S. Use of epigenetic drugs in disease: an overview. Genet Epigenet. 6: 9-19 (2014).
- Singh R, Chandel S, Dey D, et al. Epigenetic modification and therapeutic targets of diabetes mellitus. Biosci Rep. 40(9): BSR20202160 (2020).
- Bramswig NC, Kaestner KH. Epigenetics and diabetes treatment: an unrealized promise?. Trends Endocrinol Metab. 23(6): 286-291 (2012).